Back to search

Article

Protocol for Non-viral HDR-based CRISPR/Cas9 platform for small custom editing in primary T cells

2026-02-01

Abstract excerpt

<h4>Summary</h4> CRISPR/Cas9 enables precision gene editing via HDR for mutation correction and disease modelling. This protocol describes an 8-day non-viral HDR workflow for editing primary patient and healthy donor T cells, including reagent design, editing, on-target detection, and flow cytometry. The protocol was developed under research-grade conditions but supports scaling up and the transition to preclinic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
762db10f-8230-52bf-ac7a-2578d7eba071
DOI
10.64898/2026.02.01.703084
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protocol for Non-viral HDR-based CRISPR/Cas9 platform for small custom editing in primary T cellsDOI 10.64898/2026.02.01.703084
Select a neighboring publication to make it the new centre.